Josh Denny
-
May 10, 2018
Vanderbilt plays major role in nationwide “All of Us” research program — press release
-
April 5, 2018
Nashville Biosciences created to leverage wealth of data
Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development. -
March 15, 2018
Study spots undiagnosed genetic diseases in EHR
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases. -
March 1, 2018
Study reveals safety signal from genes that mimic drugs
Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center. -
October 26, 2017
Precision medicine discussion
Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture. -
October 16, 2017
Vanderbilt’s Buntin, Denny elected to National Academy of Medicine
Vanderbilt University’s Melinda Buntin, Ph.D., professor of Health Policy and chair of the department, and Joshua Denny, M.D., M.S., professor of Biomedical Informatics and Medicine and Vice President for Personalized Medicine, are among 70 new members elected to the National Academy of Medicine (NAM), the organization announced this week. -
October 7, 2016
Rheumatoid subtypes explored by PheWAS
A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.